Since 2022-Current

Hotgen established in June 2005, is a biological high-tech enterprise with the mission of “developing biotechnology and benefiting human health”.
The company continues to explore independent innovative diagnostic technology platforms, actively develops and expands liquid biopsy cancer early screening technology, and establishes a multi-omics diagnostic technology platform including protein markers, sugar chain exosomes, and DNA methylation; at the same time, it has established a future technology research institute , explore cutting-edge technologies, actively deploy biopharmaceutical fields such as antibody drugs, live bacterial drugs, and exosome drugs, and create a development strategy for the entire industry chain from diagnosis to treatment